Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are much more likely to have sleep problems and should be checked for them.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Researchers found 15 new genetic links to skin traits in Japanese women.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Insulin resistance linked to obesity may increase COVID-19 severity.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Balding people may have higher heart disease risk.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.